Background Migration of colonic lamina propria fibroblasts (CLPF) plays an important role during mucosal wound healing as well as fibrosis and fistula formation in Crohn's disease (CD). Recently, we showed that the migratory potential of CD-CLPF was significantly reduced compared to control CLPF. Fistula-derived CD-CLPF migrated less and fibrosis-CLPF more than CLPF from inflamed CD mucosa. These changes in migratory behavior were associated with changes in production of the migrationinducing fibronectin (FN) isoforms ED-A and ED-B. A permanent reduction of the migratory potential of CLPF was mediated by IFN-γ and tumor necrosis factor (TNF) modulate FN isofom expression in CLPF and thereby might regulate CLPF migration. Materials and methods Control CLPF were incubated for 72 h with IFN-γ, TNF, IFN-γ plus TNF, or TGF-β1. Messenger RNA (mRNA) was isolated and expression of FN and isoforms ED-A and ED-B was quantified by realtime polymerase chain reaction. FN, ED-A, and ED-B were investigated by Western blotting. FN receptor integrin α5β1 was analyzed by FACS. Results No difference was found for the surface display of integrin α5β1 between stimulated and non-stimulated cells. In TGF-β1 incubated CLPF mRNA amount of FN and isoforms ED-A and ED-B was slightly increased. IFN-γ only decreased FN in CLPF, TNF significantly reduced FNmRNA by 40%, FN ED-A mRNA by 25%, and ED-B mRNA by 50%. The TNF-mediated mRNA downregulation resulted in a decreased protein amount as revealed by Western blotting. Conclusion Cytokines such as IFN-γ, TNF, and TGF-β1 modulate the production of fibronectin isoforms. Our data indicate that inflammation-induced modulation of FN-isoform production is involved in the alterations of migratory potential of CLPF isolated from CD mucosa. 
Introduction
Fibronectin (FN) is an extracellular glycoprotein that mediates migration, proliferation, differentiation, and cell adhesion, and plays an important physiological role during embryonic development and tissue injury [1] .
The FNs are disulfide-linked, dimeric matrix proteins with structural type I, II, and III domains that bind to cells, collagen, proteoglycans, cell surface receptors, and fibrin [1, 2] . FNs occur in up to 20 different isoforms as a result of alternative splicing of the primary transcript in the two homologous type III domains named ED-A and ED-B and the one non-homologous repeat termed IIICS [3] [4] [5] [6] [7] . The ED-A and ED-B segments are either entirely included or excluded. The type III repeat may be included, excluded, or partially included in FN [8] [9] [10] .
The alternatively spliced FN isoforms show distinct functional differences. The expression of FN containing ED-A and ED-B domains is significantly increased during physiological wound healing and pathological tissue fibrosis [11] as found in liver-, kidney-, and lung-fibrosis [12] [13] [14] , after cardiac transplantation [15] or during vascular intimal proliferation [16] and consecutive vascular hypertension [17] . The ED-B segment, not any other domain, is also a marker of angiogenesis [18] . The splicing variant ED-A plays a role in the regulation of cell proliferation [19] and differentiation of adipocytes and of fibroblasts into myofibroblasts [20, 21] . In promoting cell spreading and cell migration, FN ED-A is significantly more potent than FN. Manabe et al. showed that insertion of the ED-A segment is followed by a change in the conformation of FN with the consequence that the Arg-Gly-Asp (RGD)-binding domain of FN is more accessible for integrin α5β1 [22] .
Integrins are a family of heterodimeric transmembrane receptors that mediate cell-extracellular matrix and cell-cell interactions [23] . Integrins interact with FN at the III14-V region and at the central cell-binding domain (CCBD). CCBD is the major cell-adhesive domain of FN and contains the RGD motif [24] , which is recognized by several integrins including α5β1, αvβ1, αvβ3, αvβ5, αvβ5, αvβ6, αIIbβ3, and α8β1, and enhances intestinal epithelial restitution [25] . Integrin α5β1 is the major FN receptor [26] .
Interactions of integrins with FN as extracellular matrix protein mediate cell adhesion and also migration via phosphorylation of kinases and α-actin filaments. Migration of human colonic lamina propria fibroblasts (CLPF) plays an important role during mucosal wound healing, fibrosis and stricture formation as well as fistula formation in Crohn's disease (CD). Recently, we demonstrated that in mucosa of patients with CD CLPF-migration is significantly reduced compared to control-CLPF [27] . Moreover, in fistula the CLPF-migration was further decreased compared to inflamed CD mucosa [28] . In addition, we have shown that FN is an essential factor for induction of migration of CLPF [29] . The altered migratory potential in CD CLPF was associated with changes in the amount of FN isoform, while expression of integrin α5β1 was unchanged [30] .
In inflamed mucosa of patients with CD, IFN-γ and TNF were found to be significantly upregulated. A comparable reduction of the migratory potential as found in CD CLPF was caused by a 3-day incubation of control CLPF with IFN-γ and TNF [27] (as a known inductor of tissue fibrosis) modulate FN isoform or integrin expression in CLPF.
Materials and methods

Patients
Primary human CLPF cultures were obtained from endoscopic biopsies or surgical resection specimens, respectively. CLPF cultures were obtained from intestinal mucosa of seven control patients with no intestinal inflammation, who underwent surgery because of colon cancer (Table 1 ). All control specimens had no inflammatory infiltrate. This study was approved by the Ethics Committee of the University of Regensburg.
Isolation and culture of human CLPF Human CLPF were isolated and cultured as previously described [31] . Briefly, the mucosa from surgical specimens was cut into 1-mm pieces while the biopsies were used directly for isolation of colonic fibroblasts. Epithelial cells were removed in Hank's Balanced Salt Solution without Ca 2+ and Mg 2+ (PAA, Cölbe, Germany) with 2 mM ethylenediaminetetraacetic acid (EDTA) (Sigma, Deisenhofen, Germany). The remaining tissue was rinsed and digested for 30 min at 37°C in phosphate-buffered saline (PBS, Gibco, Karlsruhe, Germany) containing 1 mg/ml collagenase I (Sigma), 0.3 mg/ml DNase I (Boehringer, Mannheim, Germany), and 2 mg/ml hyaluronidase (Sigma). The isolated cells were washed with Dulbecco's Modified Eagle's medium (DMEM; PAA) containing 20% fetal calf serum (FCS; Gibco) and cultured in 25-cm 2 culture flasks (Costar, Bodenheim, Germany) with DMEM containing 10% FCS, penicillin (100 IE/ml), streptomycin (100 µg/ml), ciprofloxacin (8 µg/ml), gentamycin (50 µg/ml), and amphotericin B (1 µg/ml). Non-adherent cells were removed by subsequent changes of medium. The remaining cells were used between passages 3 and 8.
Stimulation of human CLPF
Human CLPF were split when they were confluent; 1.5 −2×10 6 cells were seeded and cultured for 24 h at 37°C. Medium was removed, cells were washed twice with PBS, and cytokines in DMEM without FCS were added. CLPF were incubated for 72 h with IFN-γ (10 ng/ml), TNF (20 ng/ml), IFN-γ (10 ng/ml) and TNF-α (20 ng/ml), or TGF-β1 (20 pg/ml) at 37°C like in previous studies [27] .
FACS analysis
For fluorescence-activated cell-sorting (FACS) analysis, CLPF were detached with trypsin and resuspended in 1% BSA/PBS. For each staining, 2.5×10 5 cells were placed into 1.5-ml polypropylene tubes and 2.5 µl of the antibody solution were added. CLPF were stained for integrin subunit α5 with a fluorescein isothiocyanate (FITC)-conjugated CD49e antibody (DPC Biermann, Germany; isotype control: mouse IgG2b, Caltag, Burlingame, CA, USA) and for integrin subunit β1 with a phycoerythrin (PE)-conjugated CD29 antibody (DPC Biermann; isotype control: mouse IgG1, Caltag). Incubation was performed in the dark for 30 min on ice.
Flow cytometry was performed using an Epics XL.MCL (BeckmanCoulter, Krefeld, Germany) equipped with an argon ion laser with an excitation power of 15 mW at 488 nm. The fluorescence of 10,000 cells was collected on a linear scale through right angle scatter (side scatter), fluorescence for FITC was collected at 530 nm (FL1), and PE emission was defined by 580 nm (FL2).
Analysis gates were set around debris and intact cells on a forward scatter vs side scatter dot plot. Fluorescence dot plots were generated using the gated data. X-mean values were used for evaluation. Statistical analysis was performed with Student's t test.
RNA isolation and cDNA synthesis
For isolation of total RNA, stimulated and unstimulated primary human CLPF-cell cultures were washed twice with PBS. CLPF were scraped off, centrifuged for 5 min, and resuspended with lysis buffer from the RNeasy® kit (Qiagen, Hilden, Germany). Total RNA was prepared from these CLPF according to the manufacturer's protocol and stored at −80°C. The isolated RNA was reverse-transcribed using the Promega Reverse Transcription System (Promega, Madison, WI, USA).
Quantitative mRNA analysis by real-time PCR
The amount of FN-and ED-A-and ED-B-mRNA was quantified by real-time PCR as previously described [30] .
The released reporter dye fluorescence during the 40 cycles of amplification was monitored using Sequence Detector software (SDS version 2.0, PE Applied Biosystems). Reporter dye fluorescence vs PCR cycles was plotted. A threshold was set in the exponential phase of the fluorescence curves. The threshold cycle numbers (Ct) were calculated.
Ct values of GAPDH were subtracted from those of FN isoforms:
The mean value of the dCt values was calculated. The values of cDNA from stimulated CLPF were subtracted from those of untreated cDNA of the same CLPF: The relative start amount of cDNA was calculated in consideration of the exponential amplification:
Colonic lamina propria fibroblasts were washed with icecold PBS and incubated with 1× RIPA-lysis-buffer with proteinase inhibitor (0.05 M Tris, 0.15 M NaCl, 0.25% deoxycholate, 0.05% sodium dodecyl sulfate (SDS), 1% Triton-X-100, one tablet complete proteinase inhibitor mixture (Roche Applied Science, Mannheim, Germany) per 10 ml). CLPF were scraped off and the suspension was kept on ice for 30 min and centrifuged (4,000 rpm, 5 min at 4°C). Protein concentration in the supernatant (protein fraction) was determined by BCA assay (Sigma). Thirty micrograms of protein were mixed with protein-loading buffer containing 2× β-mercaptoethanol and boiled for 5 min before loading onto a 6% SDS-polyacrylamide gel. After electrophoresis, proteins were transferred onto nitrocellulose membranes using the Xcell II Blot Module (Invitrogen, Carlsbad, CA, USA), blocked with 5% milk in 0.1% Tween 20-PBS (Sigma) for 30 min and incubated overnight at 4°C with the indicated primary antibody. For protein immunoblots, specific antibodies to fibronectin (1:1000; 35041A, Pharmingen), fibronectin ED-A (1:400; clone IST-9, Abcam), fibronectin ED-B (1:200; PhiloMab-2, Philogen), and β-actin (1:5000; Chemicon) were used. The membranes were washed six times with 0.1% Tween 20-PBS, incubated with horseradish peroxidase-conjugated Fig. 1 a FACS analysis of integrin subunits α5-and β1 was performed in treated and untreated CLPF from control patients. Cells were immunostained with anti-integrin α5 (FL1LOG; light gray histograms), anti-integrin β1 (FL2LOG, dark gray histograms), and control antibodies (white histogram). Integrins α5 and β1 in CLPF from control patients were not changed by cytokine treatment. b No significant differences of integrin subunit α5 were found in the investigated CLPF cultures. Flow cytometry analysis was performed with five different cultures that were treated with IFN-γ (IFN), TNF and TGF-β1 (TGF). The data from a were used for the plots. Ko control. c No significant differences of integrin subunit β1 were found in the investigated CLPF cultures. Flow cytometry analysis was performed with five different cultures that were treated with IFN-γ (IFN), TNF, and TGF-β1 (TGF). The data from a were used for the plots. Ko control secondary antibodies (Santa Cruz, CA), washed again, and finally incubated with chemiluminescent substrate (ECL Plus; Amersham Biosciences, Arlington Heights, IL) for 5 min and then exposed to film (Amersham Biosciences). Exposition was quantified by a LAS 1000 (Raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany). The calculated emissions (Advanced Image Data Analyser (AIDA), version 3.52, Raytest Isotopenmessgeräte GmbH) of the FN isoforms were divided by those of the housekeeping gene β-actin. The corrected emission of the untreated control was set as 100%. After exposure, the antibody was stripped from the membrane with Re-Blot Plus-Strong (Chemicon, Hofheim, Germany) for 15 min and the blot was blocked again with 5% milk in 0.1% Tween 20-PBS before using it for the next antibody.
Statistical analysis
Statistical analysis was performed using paired t test. Real time PCR and densitometric Western blot data were pictured as boxplots. Differences between median values of two data groups were considered significant at a p value <0.05.
Results
Expression of integrin α5β1 is unchanged by INF-γ, TNF, and TGF-β1
To determine whether a reduction of the migratory potential of IFN-γ-and TNF-incubated CLPF was associated with modulation of integrin α5β1, cell surface presentation of the integrin subunits α5 and β1 was studied by FACS. CLPF isolated from intestinal mucosa of control persons were treated with 10 ng/ml IFN-γ, 20 ng/ml TNF, 10 ng/ml IFN-γ, 20 ng/ml TNF, and 20 pg/ml TGF-β1. These cytokine concentrations had been shown to be effective in modulating the migratory potential in previous studies [27] . Optimal incubation times also had been determined before. Cells were stained with FITC-and PE-conjugated antibodies directed against integrin subunit α5 and subunit β1. Non-stimulated control cells were cultured only with serum-free medium. Figure 1 shows histograms of the respective CLPF cultures. Both integrin subunits could be detected on the cell surface of all CLPF cultures (Fig. 1a) . For statistical analysis, the mean-X-values (mean fluorescence intensity) of FITC-and PE-fluorescence of five independent experiments were analyzed. No significant difference was found between untreated and cytokinestimulated CLPF for both integrin α5 (Fig. 1b) and β1 (Fig. 1c) . Fibronectin-and FN-splicing-form mRNA was quantified by real-time PCR with complementary DNA (cDNA) from seven treated and untreated CLPF cultures. The relative start amount of cDNA was calculated while the start amount of untreated control CLPF cDNA was set as one.
Colonic lamina propria fibroblasts incubated with TGF-β1 had significantly more FN (Fig. 2a) and FN ED-A  (Fig. 2b) as well as FN ED-B (Fig. 2c) Fibronectin mRNA of CLPF pre-treated with TNF was reduced by 40% (p<0.03). FN ED-A mRNA was decreased by 25%, and ED-B mRNA was 50% (p<0.04) reduced.
Incubation with IFN-γ had no significant effect on FN mRNA in CLPF.
When a combination of IFN-γ and TNF was used for the incubation of CLPF, no significant difference was observed as compared to TNF alone. The combination of IFN-γ and TNF was followed by a reduction of FN-mRNA by 40% (p<0.02), FN ED-A-mRNA expression by 30% (p<0.03), and FN ED-B-mRNA expression by 60% (p<0.00003).
Modulation of FN isoforms by IFN-γ, TNF and TGF-β1
The amounts of FN, FN ED-A, and ED-B in CLPF after stimulation with the indicated cytokines were quantified by Western blot. A typical Western blot (representative for three separate experiments) is shown in Fig. 3 . For quantification, the light emission of the Western blot bands was collected by LAS, analyzed by AIDA and compared to untreated controls for FN (Fig. 4a), FN ED-A (Fig. 4b) , and FN ED-B (Fig. 4c) . Total amounts of FN as well as the ED- IFN-γ (IFN) , TNF, IFN-γ plus TNF, and TGF-β1 (TGF), and lysed. Unstimulated cells were also lysed and used as control. The quantitative analyses of all blots were standardized to β-actin and given as the percentage compared to control (Ko; 100%). Subpanel a shows total FN, b FN ED-A, and c FN ED-B . CLPF of three control patients were used in the experiments. Paired t test: one asterisk p<0.05; two asterisks p<0.005; three asterisks p< 0.001; four asterisks p<0.0005 A and ED-B isoforms were decreased by treatment with IFN-γ by 26%, 30%, and 31%, respectively, compared to untreated CLPF. TNF-stimulation caused a 27% (FN and FN ED-A) and a 23% decrease (FN ED-B) . Both cytokines together reduced the amounts of FN, FN ED-A, and FN ED-B by 39%, 37%, and 45%, respectively, indicating here an additive effect in contrast to mRNA.
In TGF-β1-stimulated CLPF, more FN, FN ED-A, and FN ED-B was detectable compared to untreated cells. However, only the increase of FN ED-B was significant. TGF-β1-stimulation of CLPF led to an increase of FN, FN ED-A, and FN ED-B of 8%, 3%, and 36%, respectively.
Discussion
Our interest in the regulation of FN splicing was based on a line of evidence from previous studies. We had found that CLPF isolated from CD patients' mucosa had a reduced ability to migrate [27] . This functional change could be induced by incubation of CLPF from normal mucosa with IFN-γ and TNF [27] . We had recently reported that the change in the migratory behavior of CLPF in CD and CDfistula and CD-strictures was associated with corresponding alterations of the amounts of FN and the migration-or fibrosis-inducing FN-isoforms ED-A and ED-B [30] . Consequently, we wondered whether cytokines found to influence the migratory potential might exert corresponding effects on FN and FN-isoforms to further support our hypothesis that this is the mechanism by which the cytokines (at least partially) may modulate CLPF migration.
In CLPF, we indeed found a very clear reduction of FN, FN-ED-A, and ED-B mRNA and protein induced by incubation with TNF (Fig. 5) . However, TNF did not change the splicing pattern but reduced the levels of all FN isoforms, which also may explain a reduction of migration found in inflammation-associated CLPF as we had shown that FN is essential for migration of primary human CLPF [30] .
INF-γ only slightly reduced FN mRNA; however, the amount of protein in IFN-γ-treated CLPF was significantly lower compared to untreated control CLPF, an observation which further supports our hypothesis that modulation of FN and FN-isoforms may be the cause of changes in the migratory potential of CLPF during mucosal inflammation (Fig. 5) .
In inflammatory bowel disease (IBD), an imbalance between pro-inflammatory cytokines such as TNF, IFN-γ, interleukins IL-1β, IL-6, IL-8 [32] [33] [34] , and anti-inflammatory cytokines such as IL-4, IL-10, IL-13 [35, 36] plays an important role for disease pathophysiology. During inflammation and wound-healing, TNF and IFN-γ are produced by mononuclear cells. In intestinal mucosa of patients with CD and UC, TNF is secreted by activated macrophages [37] [38] [39] [40] [41] 42] . IFN-γ has also been shown to be upregulated in CD [37, 43] .
Interferons have already been reported to be inhibitors of cell migration [44] . IFN-α and IFN-γ dose-dependently inhibit migration of human skin fibroblasts [45] . Interferonmediated inhibition of migration is thought to be an important regulator of wound healing. Whether TNF induces or inhibits fibroblast migration appears to depend on the type of fibroblast. In skin fibroblasts [46] and smooth muscle cells of the aorta [47] , TNF is thought to be a chemoattractant and an activator of migration.
TGF-β1 plays a critical role in the differentiation and activation of myofibroblasts and is important during tissue repair and pathogenesis of human fibrotic diseases. Myofibroblasts and TGF-β1 are key elements for the development of the traction force associated with wound contraction and pathological contractures as seen during development of fibrotic tissue. TGF-β expression is upregulated in myofibroblasts at sites of fibrosis in experimental enterocolitis and in CD patients [48] . TGF-β potently stimulates expression of α-smooth muscle actin (SMA) [49] and certainly plays a role in the induction of collagen synthesis and matrix deposition [50] . It is involved in pathological fibrosis and fibrotic diseases of multiple tissues [51] . A role of increased TGF-β levels for tissue fibrogenesis has been shown for pulmonary fibrosis, liver fibrosis, chronic pancreatitis, scleroderma, and renal glomerulosclerosis [51] . The importance of TGF-β1 for fibrosis is not only indicated by increased production in fibrotic tissue areas, but also by the finding that administration of TGF-β1 to laboratory animals was followed by the development of fibrosis and anti-TGF-β1 therapies reduce experimentally induced fibrosis [51] . TGF-β1 upregulates fibrillar and nonfibrillar collagens, as well as fibronectin and tenascin and the basement membrane proteins laminin and entactin [52] . TGF-β1 already has been reported to change the splicing of fibronectin [51] .
In summary, in vivo and in vitro observations of CLPF migration and FN isoform expression in mucosa of CD and control patients showed several similarities (Fig. 5) . Compared to control CLPF from CD mucosa displayed a reduced migratory potential [27] and decreased protein and mRNA levels of the migration inducing factor FN [30] . Furthermore, in inflamed mucosa of CD patients increased levels of IFN-γ and TNF were observed. Incubation of normal CLPF from healthy mucosa with these cytokines reduced both the migratory potential of CLPF and the FN and FN isoform expression. Our data indicate that mediators of inflammation such as TNF or IFN-γ modulate the presence of FN and FN isoforms, thereby impairing the function of CLPF in IBD. Present IBD therapeutic strategies such as treatment of CD patients with anti-TNF antibodies may not only inhibit the inflammatory reaction, but may also preserve the migratory potential of CLPF followed by improved wound-healing. A positive effect of TNF-antibodies on so-called "mucosal healing" already has been demonstrated [53] . However, stricturing and penetrating complications of CD frequently occur over the course of the disease [54] . Anti-TNFα monoclonal antibody therapy is also effective in the treatment of fistulizing CD [55, 56] . We had demonstrated that the migratory behavior of CD fistula CLPF is further impaired [57] . TNF antibodies may potentially also enhance wound-healing in this situation by increasing CLPF migration.
Based on our data, future strategies of prevention of fibrosis or fistula formation may be more specifically targeted on the preservation of normal CLPF function. Local interventions in TNF or INF-γ signaling could represent such options.
